Reza Fathi
Directeur Technique/Scientifique/R&D chez REDHILL BIOPHARMA LTD.
Fortune : 82 477 $ au 31/05/2024
Postes actifs de Reza Fathi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REDHILL BIOPHARMA LTD. | Directeur Technique/Scientifique/R&D | 01/05/2010 | - |
Historique de carrière de Reza Fathi
Anciens postes connus de Reza Fathi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Directeur Technique/Scientifique/R&D | 01/01/2005 | - |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Directeur des opérations | 01/01/2000 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2000 | - | |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | 01/01/1991 | 01/01/1998 |
Formation de Reza Fathi
| Rutgers State University of New Jersey | Doctorate Degree |
| Texas Tech University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Israël | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REDHILL BIOPHARMA LTD. | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
- Bourse
- Insiders
- Reza Fathi
- Expérience
